NVTA has been beat up and thrown to the trash. This despite being one of the strongest names in the genetic revolution space. In a few years everyone will be talking more and more about how ballooning health costs as ever indebted governments struggle to pay the cost of treating the sick. One way to combat ballooning healthcare costs is through smarter care by anticipating illness before it happens and targeting treatment more efficiently. Genetic data is key to making that happen. NVTA is at the forefront of this technology. I would target this as a long term hold not a quick trade. I already own NVTA but will be targeting this green zone for an add as prices has come back into a nice area of support. As usual wait for price to confirm a base before entry.
評論:
Gapped up 4 dollars. Was hoping for a flush lower then reclaim. Would wait for price to settle to see if it will hold the gap or test lower again.
評論:
Getting a decent move here. Shorter term trader should trim in the 44/46 zone and trail stops as this is a volatile stock. Longer term holders I'm happy above 30.